The biological significance of iCAM-1 expression in cancer remains controversial; it is elevated in gastric, breast, oral, and thyroid cancer tissues [44–47] but reduced in some ovarian adenocarcinoma cell lines and primary tumors [48]. Here, ICAM1 is linked to ovarian adenocarcinoma.